Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Whitty JA, de Bekker-Grob EW, Cook NS, et al. Patient preferences in the medical product lifecycle. Patient. 2020;13(1):7–10. https://doi.org/10.1007/s40271-019-00400-y.
2. The PREFER Consortium. PREFER Recommendations - Why, when and how to assess and use patient preferences in medical product decision-making. 2022. Available at: https://zenodo.org/records/6592304. Accessed 19 Jan 2024.
3. Bouvy JC, Cowie L, Lovett R, Morrison D, Livingstone H, Crabb N. Use of patient preference studies in HTA decision making: a NICE Perspective. Patient. 2020;13(2):145–9. https://doi.org/10.1007/s40271-019-00408-4.
4. US FDA. Benefit-Risk Assessment for New Drug and Biological Products. Guidance for Industry. Silver Spring, MD: US FDA; 2023.
5. Janssens R, Barbier L, Muller M, et al. How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action. Front Pharmacol. 2023;14:1192770. https://doi.org/10.3389/fphar.2023.1192770.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献